Nest Health, the leading family-centered, home-based healthcare provider for high-risk families, has officially announced the launch of Nest Rooted Recovery, which happens to be a new Medication for Opioid Use Disorder (MOUD) program.
According to certain reports, the program in question brings an evidence-based addiction treatment right into the patient’s home, while simultaneously integrating ongoing medical, behavioral, and social care for the entire family.
More on the same would reveal how, unlike your traditional programs best known for addressing substance use disorder or mental health in isolation, Nest Rooted Recovery is actually embedded within Nest’s fully integrated care model. As a result, participating adults should not just expect life-saving addiction treatment, but at the same time, they can also come expecting continuous access to primary care, chronic condition management, mental health services, and social care.
In case that wasn’t enough, this whole proposition is accessible both at home and online, dispatched by the experienced Nest care team in each scenario.
To understand the significance of such a development, we must take into account one CDC report, where it was revealed that more than 108,000 people across U.S. died from drug overdoses, with opioids, especially fentanyl, responsible for a large chunk of it. Despite there being such a staggering prevalence, though, fewer than 36% of individuals with opioid use disorder would actually go on to receive any treatment.
Against that, Nest Health’s Rooted Recovery program treads up a long distance to address the same by eliminating common barriers to care, including transportation, stigma, and fragmented services, instead meeting patients right at home.
Talk about the given program on a slightly deeper level, it takes inspiration from SAMHSA, ACOG, WHO, CDC, and NIDA to provide, for starters, in-home clinical assessments that study opioid dependence severity (DSM-5 criteria), concurrent substance use, infectious diseases, toxicology (including fentanyl), as well as social determinants of health.
Next up, the initiative in question brings forth a facility to conceive medication initiation and monitoring. This it does using FDA-approved treatments and medications, primarily buprenorphine/naloxone, prescribed following safety-focused protocols to minimize withdrawal symptoms.
Another detail worth a mention is rooted in the potential for pharmacy coordination, something which ensures that patients have timely access of medications and overdose prevention tools like naloxone.
Hold on, we still have a few bits left to unpack, considering we haven’t yet touched upon an aspect committed to constant monitoring. Here, Nest Health’s latest brainchild effectively banks upon frequent provider check-ins during the first 72 hours, along with education on medication management and emergency response, to achieve its objective.
We also haven’t touched upon the initiative’s pledge to realize seamless transitions with warm handoffs to long-term recovery partners, including Odyssey House for in-person support and Eleanor Health for telehealth-based care.
Rounding up highlights would be program’s focus on ongoing medical, mental, and social care. This involves regular recovery support, primary care, sick care, chronic disease management, specialist coordination, and check-ins with mental health specialists, delivering continuity and spotting potential hiccups across every discipline.
“I’m so proud of this program — it provides much-needed access to treatment into the homes of families who deserve compassionate support, dignity, and a real chance at recovery,” said Kelsie Brandt, Chief Clinical Officer at Nest Health. “Our incredible clinical team provides care in the real context of people’s lives, always without judgment, with an unwavering commitment to helping our families thrive.”
